Bristol-Myers Squibb: all 2,184 studies

Page 8 of 22. Open to participants first (162), then studies with results posted, then the rest; newest registration first within each.

• Efficacy and Safety Study of Apixaban for Extended Treatment of Deep Vein Thrombosis or Pulmonary EmbolismCompletedNCT00633893Phase 3Results posted
• Evaluation of Tumor Response to Ipilimumab in the Treatment of Melanoma With Brain MetastasesCompletedNCT00623766Phase 2Results posted
• A Companion Study for Studies THAL-MM-003, CC-5013-MM-009, and CC-5013-MM-010 for Subjects With Multiple MyelomaCompletedNCT00622336Phase 3Results posted
• A Phase IIIb Study to Compare Entecavir Plus Tenofovir vs. Adefovir Added to Continuing Lamivudine Therapy in Adult Patients With Lamivudine-Resistant Hepatitis B InfectionTerminatedNCT00605384Phase 3Results posted
• Belatacept Pharmacokinetic Trial in Renal TransplantationCompletedNCT00578448Phase 2Results posted
• Subcutaneous Pharmacokinetics of BelataceptCompletedNCT00569803Phase 1Results posted
• Dasatinib in Combination With Revlimid (and Dexamethasone)CompletedNCT00560391Phase 1Results posted
• Safety Study of Dasatinib With Bortezomib (Velcade®) and Dexamethasone for Multiple MyelomaTerminatedNCT00560352Phase 1Results posted
• Methotrexate-Inadequate Response StudyCompletedNCT00559585Phase 3Results posted
• Belatacept in Liver Transplant RecipientsTerminatedNCT00555321Phase 2Results posted
• Phase IIIB Subcutaneous Abatacept Monotherapy StudyCompletedNCT00547521Phase 3Results posted
• A Single Ascending Dose Study of Daclatasvir (BMS-790052) in Hepatitis C Virus Infected SubjectsCompletedNCT00546715Phase 1/2Results posted
• Albumin-bound Paclitaxel (ABI-007) for Patients With Advanced Non-Small Cell Lung CancerCompletedNCT00540514Phase 3Results posted
• A Phase I/II Study to Determine the Maximum Tolerated Dose (MTD) and Safety of CC-4047 (Pomalidomide) Administered in Conjunction With Cisplatin and EtoposideTerminatedNCT00537511Phase 1/2Results posted
• Safety and Efficacy of Abatacept Versus Placebo in Participants With Psoriatic ArthritisTerminatedNCT00534313Phase 2Results posted
• Phase IIIB Subcutaneous Missed Dose StudyCompletedNCT00533897Phase 3Results posted
• Dasatinib in Imatinib Resistant/Intolerant Chinese CML (Chronic and Advanced Phase) SubjectsCompletedNCT00529763Phase 2Results posted
• Phase II Study for Previously Untreated Subjects With Non Small Cell Lung Cancer (NSCLC) or Small Cell Lung Cancer (SCLC)CompletedNCT00527735Phase 2Results posted
• Prevention of Restenosis Following RevascularizationTerminatedNCT00518284Phase 2Results posted
• A Phase 4 Study to Assess the Effects of Aripiprazole Versus Other Atypical Antipsychotics in the Treatment of Schizophrenic Patients With Metabolic SyndromeTerminatedNCT00508157Phase 4Results posted
• A Phase III Study of Apixaban in Patients With Atrial FibrillationCompletedNCT00496769Phase 3Results posted
• A Study to Evaluate the Discontinuation Effect of Clopidogrel After Drug Eluting Stent Implantation in Non-diabetic PatientsCompletedNCT00493779Phase 4Results posted
• Immunogenicity and Safety Study of Topical Recombinant Thrombin in Surgical HemostasisCompletedNCT00491608Phase 3Results posted
• A Phase III Study of Abatacept in Japanese Subjects With Rheumatoid ArthritisCompletedNCT00484289Phase 3Results posted
• A Study of Dasatinib in Chronic Phase Philadelphia Chromosome Positive Chronic Myeloid LeukemiaCompletedNCT00482703Phase 1/2Results posted
• A Phase III Study of Dasatinib vs Imatinib in Patients With Newly Diagnosed Chronic Phase Chronic Myeloid LeukemiaCompletedNCT00481247Phase 3Results posted
• A Multicenter, Single-Arm, Open-Label Expanded Access Program for Lenalidomide Plus Dexamethasone in Previously Treated Subjects With Multiple MyelomaCompletedNCT00478777Phase 3Results posted
• A Study to Evaluate Lenalidomide Combined With Dexamethasone in Relapsed or Refractory Diffuse Large B-Cell LymphomaTerminatedNCT00474188Phase 2Results posted
• A Phase II Study of Pomalidomide in Myelofibrosis With Myeloid MetaplasiaCompletedNCT00463385Phase 2Results posted
• Phase 2 Clinical Trial of NPI-0052 in Patients With Relapsed or Relapsed/Refractory Multiple MyelomaCompletedNCT00461045Phase 2Results posted
• Study of Apixaban for the Prevention of Thrombosis-related Events in Patients With Acute Medical IllnessCompletedNCT00457002Phase 3Results posted
• First Line Therapy for Patients With Metastatic Breast CancerTerminatedNCT00456846Phase 2Results posted
• Study to Assess Effectiveness of Giving Combination of Standard Chemotherapy Drugs Versus Combination of Standard Chemotherapy and New Drug Ixabepilone When Given Before Surgical Removal of Early Stage Breast CancerCompletedNCT00455533Phase 2Results posted
• A Phase II Study of Belatacept (BMS-224818) With a Steroid-free Regimen in Subjects Undergoing Kidney TransplantationCompletedNCT00455013Phase 2Results posted
• Phase I Study of Dasatinib (BMS-354825) and Capecitabine for Women With Advanced Breast CancerCompletedNCT00452673Phase 1Results posted
• Study of an Investigational Drug for the Prevention of Thrombosis-related Events Following Knee Replacement SurgeryCompletedNCT00452530Phase 3Results posted
• A Study of MDX-1106 in Patients With Selected Refractory or Relapsed MalignanciesCompletedNCT00441337Phase 1Results posted
• Study of Dasatinib and Docetaxel in Metastatic Hormone Refractory Prostate CancerCompletedNCT00439270Phase 1/2Results posted
• Efficacy and Safety Study of Abatacept to Treat Lupus NephritisTerminatedNCT00430677Phase 2/3Results posted
• A Trial of Romidepsin for Progressive or Relapsed Peripheral T-cell LymphomaCompletedNCT00426764Phase 2Results posted
• A Study of CC-5013 Plus Dexamethasone Versus Dexamethasone Alone in Previously Treated Subjects With Multiple MyelomaCompletedNCT00424047Phase 3Results posted
• A Study of Entecavir in Pediatric Patients With Chronic Hepatitis B Virus (HBV)-InfectionCompletedNCT00423891Phase 1/2Results posted
• Study of an Investigational Drug for the Prevention of Thrombosis-related Events Following Hip Replacement Surgery (ADVANCE-3)CompletedNCT00423319Phase 3Results posted
• A Multicentre, Single-arm, Open-label Safety Study of Lenalidomide Plus Dexamethasone in Previously Treated Subjects With Multiple MyelomaCompletedNCT00420849Phase 3Results posted
• A Phase IIIb Study of BMS-188667 in Subjects With Active Rheumatoid Arthritis and Inadequate Response to MethotrexateCompletedNCT00420199Phase 3Results posted
• A Study of Revlimid in the Treatment of Non-Hodgkin's LymphomaCompletedNCT00413036Phase 2Results posted
• Apixaban for the Prevention of Stroke in Subjects With Atrial FibrillationCompletedNCT00412984Phase 3Results posted
• A Study of Abatacept in Patients With Active Ulcerative ColitisCompletedNCT00410410Phase 3Results posted
• Entecavir Plus Adefovir Combination Therapy Versus Entecavir Monotherapy vs Therapy With Adefovir Plus Lamivudine for Chronic Hepatitis B Infected Subjects With Lamivudine-resistant VirusCompletedNCT00410202Phase 3Results posted
• Entecavir Plus Tenofovir Combination Therapy Versus Entecavir Monotherapy in Naive Subjects With Chronic Hepatitis BCompletedNCT00410072Phase 3Results posted
• A Phase III Study of Abatacept in Patients With Rheumatoid Arthritis and an Inadequate Response to MethotrexateCompletedNCT00409838Phase 3Results posted
• A Study of Abatacept in Patients With Active Crohn's DiseaseTerminatedNCT00406653Phase 3Results posted
• A Study to Compare MPR With MP in Newly Diagnosed Multiple Myeloma Subjects 65 Years Old or Older.CompletedNCT00405756Phase 3Results posted
• A Study of BMS-224818 (Belatacept) in Patients Who Have Undergone a Kidney Transplant and Are Currently on Stable Cyclosporine or Tacrolimus Regimen With or Without CorticosteroidsCompletedNCT00402168Phase 2Results posted
• Gemcitabine Plus Albumin-bound Paclitaxel In Patients With Advanced Metastatic Pancreatic CancerCompletedNCT00398086Phase 1/2Results posted
• Antiviral Activity of Entecavir in Patients Receiving Liver Transplant Due to Chronic Hepatitis B Virus InfectionCompletedNCT00395018Phase 3Results posted
• Study of Dose-dense Adriamycin Plus Cytoxan (AC) Followed by Either ABI-007 (Abraxane) or Taxol With Bevacizumab as Adjuvant Therapy for Patients With Breast CancerCompletedNCT00394251Phase 2Results posted
• ABI-007 In Combination With Bevacizumab in Women With Metastatic Breast CancerCompletedNCT00394082Phase 2Results posted
• A Study in Korea of Entecavir Versus Lamivudine in Adults With Chronic Hepatitis B InfectionCompletedNCT00393484Phase 4Results posted
• Study of Entecavir in Patients With Chronic Hepatitis B Virus (HBV) InfectionCompletedNCT00388674Results posted
• Phase II Study of Dasatinib (BMS-354825) for Androgen-deprived Progressive Prostate CancerCompletedNCT00385580Phase 2Results posted
• A Study of Romidepsin (Depsipeptide) in Combination With Gemcitabine in Patients With Pancreatic and Other Advanced Solid TumorsCompletedNCT00379639Phase 1Results posted
• Study of Apixaban for the Prevention of Thrombosis-related Events Following Knee Replacement SurgeryCompletedNCT00371683Phase 3Results posted
• Study of Dasatinib (BMS-354825) in Patients With Advanced Estrogen/Progesterone Receptor-positive (ER+/PR+) or Her2/Neu-positive (Her2/Neu+)Breast CancerCompletedNCT00371345Phase 2Results posted
• A Study of Dasatinib (BMS-354825) in Patients With Advanced 'Triple-negative' Breast CancerCompletedNCT00371254Phase 2Results posted
• Effect of Entecavir in Blacks/African Americans and Hispanics With Chronic Hepatitis B Virus (HBV) InfectionCompletedNCT00371150Phase 4Results posted
• Safety, Tolerability and Pharmacokinetics of Efavirenz in HIV-Infected ChildrenCompletedNCT00364793Phase 1/2Results posted
• A Study of Dasatinib vs. High-Dose Imatinib (600 mg) in Patients With Chronic Phase Chronic Myeloid Leukemia (CML) Who Failed to Achieve Complete Cytogenetic Response After 3-18 Months of Imatinib TherapyTerminatedNCT00362466Phase 3Results posted
• A Phase II Open Label Study of BMS-582664 in Locally Advanced or Metastatic Hepatocellular CancerCompletedNCT00355238Phase 2Results posted
• Study of Dasatinib (BMS-354825) in Patients With Solid TumorsCompletedNCT00339144Phase 1Results posted
• Phase IIIb Study to Evaluate the Effectiveness and Safety of Atazanavir/Ritonavir as Single Enhanced Protease Inhibitor Therapy in Human Immunodeficiency Virus (HIV)-Infected Subjects Evidencing Virologic SuppressionCompletedNCT00337467Phase 3Results posted
• Pharmacokinetics of Atazanavir/Ritonavir in HIV-1 Infected Pregnant WomenCompletedNCT00326716Phase 1Results posted
• Dacarbazine and Ipilimumab vs. Dacarbazine With Placebo in Untreated Unresectable Stage III or IV MelanomaCompletedNCT00324155Phase 3Results posted
• Study of MDX-010 in Patients With Metastatic Hormone-Refractory Prostate CancerCompletedNCT00323882Phase 1/2Results posted
• A Phase 2 Pilot Study of Apixaban for the Prevention of Thromboembolic Events in Patients With Advanced (Metastatic) CancerCompletedNCT00320255Phase 2Results posted
• Study of Dasatinib in Patients With Chronic Phase Chronic Myeloid Leukemia and a Suboptimal Response to ImatinibTerminatedNCT00320190Phase 2Results posted
• Safety Study of Apixaban in Recent Acute Coronary SyndromeCompletedNCT00313300Phase 2Results posted
• Study of Dasatinib in Children and Adolescents With Relapsed or Refractory LeukemiaCompletedNCT00306202Phase 1Results posted
• Weekly vs. Every 2 Week vs. Every 3 Week Administration of ABI-007 (Abraxane)/Bevacizumab Combination in Metastatic Breast CancerTerminatedNCT00281528Phase 2Results posted
• Phase II Trial Comparing ABI-007 (Abraxane®, Nab®-Paclitaxel) to Taxotere in First Line Therapy of Patients With Stage IV Breast CancerCompletedNCT00274456Phase 2Results posted
• BMS-Reyataz Study in Treatment in Naive Subjects to Compare the Efficacy and Safety Between Boosted Reyataz and Kaletra When in Combination With Fixed Dose TruvadaCompletedNCT00272779Phase 3Results posted
• Belatacept Evaluation of Nephroprotection and Efficacy as First-line Immunosuppression (BENEFIT)CompletedNCT00256750Phase 3Results posted
• Study to Assess Steady-State Trough Concentrations, Safety, and Immunogenicity of Abatacept After Subcutaneous (SC) Administration to Subjects With Rheumatoid Arthritis (RA)CompletedNCT00254293Phase 1/2Results posted
• Use of ABI-007 for the Prevention of Vascular Access Graft Failure in Patients Undergoing HemodialysisTerminatedNCT00249002Phase 2Results posted
• Induction-Maintenance With Atazanavir in HIV Naïve Patients (The INDUMA Study)CompletedNCT00207142Phase 4Results posted
• Lenalidomide (Revlimid®, CC-5013) in Subjects With Relapsed or Refractory Indolent Non-Hodgkin's LymphomaCompletedNCT00179673Phase 2Results posted
• Safety And Efficacy Of Lenalidomide In Patients With Relapsed Or Refractory Aggressive Non-Hodgkin's Lymphoma (NHL)CompletedNCT00179660Phase 2Results posted
• Expanded Access Program:Lenalidomide With or Without Dexamethasone In Previously Treated Subjects With Multiple MyelomaCompletedNCT00179647Phase 3Results posted
• Lenalidomide Versus Placebo in Myelodysplastic Syndromes With a Deletion 5q[31] AbnormalityCompletedNCT00179621Phase 3Results posted
• Abatacept With Methotrexate- Phase IIBCompletedNCT00162266Phase 2Results posted
• A Companion Study for Patients Enrolled in Prior/Parent Ipilimumab StudiesCompletedNCT00162123Phase 2Results posted
• Pharmacokinetics of Efavirenz in HIV-1 Infected Subjects With Hepatic ImpairmentCompletedNCT00162097Phase 1Results posted
• A Phase I/II Study of ABI-007 (Abraxane®, Nab®-Paclitaxel)and Vinorelbine in Patients With Stage IV (Metastatic) Breast CancerTerminatedNCT00140140Phase 1/2Results posted
• Study of Reyataz in HIV-infected Patients With Lipodystrophy SyndromeCompletedNCT00135356Phase 4Results posted
• Study of Abatacept (BMS-188667) in Subjects With Active Rheumatoid Arthritis on Background Non-biologic DMARDS (Disease Modifying Antirheumatic Drugs) Who Have an Inadequate Response to Anti-TNF TherapyCompletedNCT00124982Phase 3Results posted
• Use of Nanoparticle Paclitaxel (ABI-007) for the Prevention of In-Stent RestenosisCompletedNCT00124943Phase 1/2Results posted
• Study of Abatacept Versus Placebo to Assess the Prevention of Rheumatoid Arthritis (RA) in Adult PatientsCompletedNCT00124449Phase 2Results posted
• Advanced Chronic Myelogenous Leukemia (CML) - Follow On: Study of BMS-354825 in Subjects With CMLCompletedNCT00123487Phase 3Results posted
• Chronic Myelogenous Leukemia (CML) - Follow on: Study of BMS-354825 in Subjects With CMLCompletedNCT00123474Phase 3Results posted
• Remission and Joint Damage Progression in Early Rheumatoid ArthritisCompletedNCT00122382Phase 3Results posted

← Bristol-Myers Squibb overview and focus areas